Actavis Elizabeth Alprazolam Orally Disintegrating Tablets Recall

Why it was recalled

Failed Tablet/Capsule Specifications; partial tablet erosion resulting in tablet weights below specification in some tablets

Product description

Alprazolam Orally Disintegrating Tablets, USP 2 mg, 100 count bottles, Rx Only, MFG. BY ACTAVIS ELIZABETH LLC., Elizabeth, NJ, NDC 0228-4025-11

Lot numbers, UPCs & expiration codes

Lot # 59380831, Exp. May 2014

Where it was sold

Nationwide

What to do if you have this product

Compare the lot number and expiration date on your package with the codes above.
Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
If you have symptoms you think are related, contact your doctor. In an emergency call 911.
Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number: D-018-2014
Classification: Class II
Status: Terminated
Recall initiated: Oct 9, 2013
FDA report date: Dec 4, 2013
Quantity: 756 bottles
Recall type: Voluntary: Firm initiated
Recalling firm: Actavis Elizabeth LLC

Original FDA data

Every field from FDA enforcement report D-018-2014, exactly as published.

Show all FDA fields

City: Elizabeth
State: NJ
Status: Terminated
Country: United States
Event ID: 66528
Address: 200 Elmora Ave
Code information: Lot # 59380831, Exp. May 2014
Postal code: 07202-1106
Report date: Dec 4, 2013
Product type: Drugs
Recall number: D-018-2014
Classification: Class II
Recalling firm: Actavis Elizabeth LLC
Product quantity: 756 bottles
Termination date: Nov 3, 2014
Reason for recall: Failed Tablet/Capsule Specifications; partial tablet erosion resulting in tablet weights below specification in some tablets
Voluntary / mandated: Voluntary: Firm initiated
Product description: Alprazolam Orally Disintegrating Tablets, USP 2 mg, 100 count bottles, Rx Only, MFG. BY ACTAVIS ELIZABETH LLC., Elizabeth, NJ, NDC 0228-4025-11
Distribution pattern: Nationwide
Recall initiation date: Oct 9, 2013
Initial firm notification: Letter
Center classification date: Nov 22, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-018-2014, published Dec 4, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: Oct 2, 2026. Content last changed: Oct 2, 2026.

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.